RNS Number : 4009S
McBride PLC
14 June 2024
 

14 June 2024

 

 

Notification and public disclosure of the grant and vesting of RSU Awards to Persons Discharging Managerial Responsibilities ("PDMR")

 

 

 

In accordance with our remuneration policy, McBride plc confirms the following transactions in respect of Chris Smith, Chief Executive Officer of McBride plc:

 

(i)         On 11 June 2024, an award was granted under the terms of the McBride plc 2020 Restricted Share Unit Plan (the Plan) to Chris Smith as set out in the table below. The award will vest at the end of a three-year period and be subject to a two-year post-vesting holding period and will not require any payment from the individual.

 

(ii)        On 11 June 2024, an award over ordinary shares in McBride plc granted on 11 June 2021 to Chris Smith (the Award) vested under the terms of the Plan.  The Award vested at the end of a three-year period and the number of ordinary shares vesting was 74,382 (the Shares). Following vesting of the Award, 34,959 Shares were sold to cover the income tax and National Insurance liability arising upon vesting. Details of the transactions are set out in the table below.

 

 

This announcement and the following disclosure is made in accordance with Article 19(1) of the UK Market Abuse Regulation.

 

 

1.

Details of the Persons Discharging Managerial Responsibilities ("PDMR")/Relevant Employees/Person Closely Associated ("PCA")

a)

Name

 

Chris Smith

2.

Reason for the notification

b)

Position/Status

Chief Executive Officer

 

c)

Initial notification/amendment

 

Initial Notification

 

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

McBride plc

 

b)

LEI

213800HX7FMPA2CIEF02

 

4.

Details of the transaction(s)

Section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification Code

Ordinary shares of 10p each

 

 

GB0005746358

 

b)

Nature of the transaction

 

Grant of a conditional award of shares under the Company's 2020 Restricted Share Unit Plan

 

c)

Price(s) and volume(s)

 

 

 

 

 

Price(s)

Volume(s)

Nil

 

119,652

d)

Aggregated information

Aggregated volume

Price

 

N/A - single transaction

e)

Date of the transaction

 

11 June 2024

 

f)

Place of transaction

 

Outside of a trading venue

4.

Details of the transaction(s)

Section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

Description of the financial instrument, type of instrument

 

Identification Code

 

Ordinary shares of 10p each

 

 

GB0005746358

 

 

 

b)

Nature of the transaction

 

Vesting of a conditional award of shares under the Company's 2020 Restricted Share Unit Plan

 

 

c)

Price(s) and volume(s)

 

 

 

 

 

Price(s)

Volume(s)

Nil

 

74,382

d)

Aggregated information

Aggregated volume

Price

 

N/A - single transaction

e)

Date of the transaction

 

11 June 2024

 

f)

Place of transaction

 

Outside of a trading venue

4.

Details of the transaction(s)

Section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

Description of the financial instrument, type of instrument

 

Identification Code

 

Ordinary shares of 10p each

 

 

GB0005746358

 

b)

Nature of the transaction

 

Sale of Shares

 

c)

Price(s) and volume(s)

 

 

 

 

 

Price(s)

Volume(s)

1.135

 

34,959

 

 

d)

Aggregated information

Aggregated volume

Price

 

N/A - single transaction

e)

Date of the transaction

 

12 June 2024

 

f)

Place of transaction

 

London Stock Exchange

 

 

 

 

 

 

 

 

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFJMRTMTIBBAI